Monday, September 28, 2026
The Cancer News

AN AUTHORITATIVE RESOURCE FOR EVERYTHING ABOUT CANCER

Carolina Schinke, MD

Carolina Schinke, MD

associate professor of medicine

Carolina Schinke, MD, is associate professor of medicine at the Myeloma Center at the University of Arkansas for Medical Sciences (UAMS), one of the most comprehensive myeloma treatment and research programs in the country. Her practice focuses on plasma cell disorders, including multiple myeloma and amyloidosis, with particular attention to T-cell redirecting immunotherapies such as chimeric antigen receptor (CAR) T-cell therapy and bispecific antibodies. Her research includes multi-institutional real-world outcomes studies of teclistamab and talquetamab in relapsed and refractory disease. Fellowship training in hematology and medical oncology was completed at Montefiore Medical Center and Albert Einstein College of Medicine.

Published Articles (1)

Sequencing CAR-T and Bispecific Antibodies in Multiple Myeloma: What the Data Show

September 28, 2026

CAR-T cell therapy and bispecific antibodies have transformed relapsed multiple myeloma, but sequencing matters.